Untangling the Role of Polycomb Complexes in Chemotherapy Resistance Academic Article uri icon

Overview

MeSH Major

  • B-Lymphocytes
  • Basic-Leucine Zipper Transcription Factors
  • DNA-Binding Proteins
  • Pre-B Cell Receptors
  • Precursor Cells, B-Lymphoid

abstract

  • ©2018 American Association for Cancer Research. In this issue, Maganti and colleagues described an epigenetic link between reduced abundance of Polycomb-related protein MTF2 and chemotherapy resistance in refractory acute myeloid leukemia. MTF2 deficiency impaired expression of the PRC2 complex and deposition of H3K27me3 at many genes, including the key target gene MDM2, leading to increased MDM2 expression that in turn depleted p53 and thereby conferred chemoresistance. Cancer Discov; 8(11); 1348-51. ©2018 AACRSee related article by Maganti et al., p. 1376.

publication date

  • November 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1158/2159-8290.CD-18-1080

PubMed ID

  • 30385522

Additional Document Info

start page

  • 1348

end page

  • 1351

volume

  • 8

number

  • 11